Related Experiment Video
Updated: Jul 30, 2025

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
Published on: September 19, 2018
A Systematic Review and Meta-Analysis of the Incidence and Risk Factors for Major Adverse Cardiovascular Events in
Chinmay Sharma1, Tejas P Singh2, Shivshankar Thanigaimani1,3
1Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia.
Insights
Patients with unrepaired abdominal aortic aneurysms (AAA) face a high risk of major adverse cardiovascular events (MACE). Preventative medication use is suboptimal, highlighting the need for enhanced secondary prevention strategies in this vulnerable group.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Epidemiology
Background:
- Major adverse cardiovascular events (MACE), encompassing myocardial infarction (MI), stroke, and cardiovascular death, contribute significantly to morbidity and mortality.
- Abdominal aortic aneurysm (AAA) is a serious vascular condition associated with increased cardiovascular risk.
Purpose of the Study:
- To assess the incidence rate of MACE in patients with unrepaired AAA.
- To examine the association of MACE with modifiable risk factors and medication use (aspirin, statins) in this population.
Main Methods:
- Systematic review and meta-analysis of observational studies.
- Inclusion of studies reporting incidence of MI, stroke, or cardiovascular death in patients with unrepaired AAAs.
- Primary outcome: cardiovascular death incidence rate (events per 100 person-years).
Main Results:
- Fourteen studies with 69,579 participants (mean follow-up 5.4 years) were included.
- Incidence rates per 100 person-years: cardiovascular death (2.31), MI (1.65), and stroke (0.89).
- Mean statin and aspirin prescription rates were 58.1% and 53.5%, respectively, indicating suboptimal use.
Conclusions:
- Patients with unrepaired AAA experience a substantial incidence of MACE.
- The prescription rates for secondary preventative medications like statins and aspirin are suboptimal in this cohort.
- There is a critical need to enhance secondary prevention efforts for patients with unrepaired AAA.
Abstract:
Major adverse cardiovascular events (MACE), including myocardial infarction (MI), stroke and cardiovascular death, cause substantial morbidity and mortality. This review assessed the incidence rate of MACE and the association with modifiable risk factors (diabetes, hypertension) and medication use (aspirin, statins) in patients with unrepaired abdominal aortic aneurysm (AAA). Electronic databases were searched systematically for observational studies reporting the incidence of MI, stroke or cardiovascular death in patients with unrepaired AAAs. The primary outcome was cardiovascular death reported as an incidence rate (events per 100 person-years (PY)). Fourteen studies, including 69,579 participants with a mean follow-up time of 5.4 years, were included. Meta-analysis revealed the overall incidence of cardiovascular death, MI and stroke of 2.31 per 100 PY (95% CI, 1.63-3.26; I2 = 98%), 1.65 per 100 PY (95% CI, 1.01-2.69, I2 = 88%) and 0.89 per 100 PY (95% CI, 0.53-1.48, I2 = 87.0%), respectively. The mean rates of statin and aspirin prescriptions were 58.1% and 53.5%, respectively. In conclusion, there is a substantial incidence of MACE in patients with unrepaired AAA, but the prescription of preventative medication is suboptimal. Greater emphasis should be placed on secondary prevention in this population.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction
Aneurysm IV: Nursing Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction

